möglich sobald bei der ZB eingereicht worden ist.
Validation strategies for antibodies targeting modified ribonucleotides.
RNA 26, 1489-1506 (2020)
Chemical modifications are found on almost all RNAs and affect their coding and noncoding functions. The identification of m(6)A on mRNA and its important role in gene regulation stimulated the field to investigate whether additional modifications are present on mRNAs. Indeed, modifications including m(1)A, m(5)C, m(7)G, 2'-OMe, and Psi were detected. However, since their abundances are low and tools used for their corroboration are often not well characterized, their physiological relevance remains largely elusive. Antibodies targeting modified nucleotides are often used but have limitations such as low affinity or specificity. Moreover, they are not always well characterized and due to the low abundance of the modification, particularly on mRNAs, generated data sets might resemble noise rather than specific modification patterns. Therefore, it is critical that the affinity and specificity is rigorously tested using complementary approaches. Here, we provide an experimental toolbox that allows for testing antibody performance prior to their use.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
4.320
0.890
3
9
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Monoclonal Antibodies ; Affinity ; M(6)a ; M(5)c ; Validation ; Base Modifications; Messenger-rna; Ribosomal-rna; M(6)a; Methylation; Pseudouridylation; Nuclear; N-6-methyladenosine; 5-methylcytosine; Proteins
Sprache
englisch
Veröffentlichungsjahr
2020
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
1355-8382
e-ISSN
1469-9001
Zeitschrift
RNA
Quellenangaben
Band: 26,
Heft: 10,
Seiten: 1489-1506
Verlag
Cold Spring Harbor Laboratory Press
Verlagsort
1 Bungtown Rd, Cold Spring Harbor, Ny 11724 Usa
Begutachtungsstatus
Peer reviewed
Institut(e)
CF Monoclonal Antibodies (CF-MAB)
Research Unit Molecular Immune Regulation (AMIR)
Research Unit Molecular Immune Regulation (AMIR)
POF Topic(s)
30201 - Metabolic Health
30203 - Molecular Targets and Therapies
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Helmholtz Diabetes Center
Immune Response and Infection
Immune Response and Infection
PSP-Element(e)
G-502210-001
G-501712-001
G-501712-001
WOS ID
WOS:000570798100015
Scopus ID
85091191629
Erfassungsdatum
2020-11-06